Device Trial Radar · NCT04226547
Amplatzer Amulet LAAO vs. NOAC
Last checked: Nov 19, 2026Latest source record: Feb 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
2,650
Planned (sponsor's estimate)
Start
Jul 7, 2020
Primary completion
Jan 2029
Study completion Apr 2031
Sponsor
- Lead sponsor
- Abbott Medical DevicesPublic (ABT)
- Sponsor type
- Industry
- First posted
- Jan 13, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this trial is to evaluate the safety and effectiveness of the Amulet LAA occluder compared to NOAC therapy in patients with non-valvular AF at increased risk for ischemic stroke and who are recommended for long-term NOAC therapy. The clinical investigation is a prospective, randomized, multicenter active control worldwide trial. Subjects will be randomized in a 1:1 ratio between the Amulet LAA occlusion device ("Device Group") and a commercially available NOAC medication ("Control Group"). The choice of NOAC in the Control Group will be left to study physician discretion.
Conditions
- Atrial Fibrillation
- Stroke
- Bleeding
Interventions
Left Atrial Appendage Occlusion (Amplatzer Amulet LAA Occluder)Device
Implantation of an Amplatzer Amulet left atrial appendage occluder
Non-Vitamin K Oral AntagonistsDrug
Initiation or continuation of a NOAC drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Composite of ischemic stroke, systemic embolism, or cardiovascular (CV) mortalityTime frame: 2 years
- Major bleeding or clinically relevant non-major bleeding (CRNMB) events, excluding procedure related eventsTime frame: 2 years
- Composite of ischemic stroke or systemic embolismTime frame: 3 years
Locations
127 sites in 16 countries. Site status is shown where the registry gives one.
University Hospital - Univ. of Alabama at Birmingham (UAB)
Birmingham, Alabama
Heart Center Research, LLC
Huntsville, Alabama
Arizona Cardiovascular Research Center
Phoenix, Arizona
124 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.